About This Page
This is a clinician-written, evidence-based summary aligned to the USMLE Step 2 CK Content Outline. It is intended for medical students preparing for USMLE Step 2 CK. Management reflects current ACC/AHA, USPSTF, and APA guidelines. Always cross-reference with UpToDate, institutional protocols, and clinical judgment.
The Bottom Line
- Diabetic retinopathy is the leading cause of new blindness in working-age adults in the United States
- Nonproliferative disease: microaneurysms, dot-blot hemorrhages, hard exudates, cotton-wool spots, venous beading, IRMA
- Proliferative disease = neovascularization; complications include vitreous hemorrhage and traction retinal detachment
- Diabetic macular edema can occur at any stage and is a major cause of central vision loss
- Management: glycemic/BP control, anti-VEGF for center-involved macular edema or proliferative disease, and panretinal photocoagulation for high-risk PDR
Overview
Diabetic retinopathy is a diabetes-related retinal microangiopathy driven by chronic hyperglycemia, capillary basement membrane thickening, pericyte loss, ischemia, vascular leakage, and VEGF-mediated neovascularization. It is classified as nonproliferative diabetic retinopathy (NPDR) or proliferative diabetic retinopathy (PDR). Diabetic macular edema (DME) is retinal thickening from vascular leakage at the macula and can occur with either NPDR or PDR.
Epidemiology
Risk increases with diabetes duration and poor glycemic control. After 20 years of diabetes, most patients with type 1 diabetes and many with type 2 diabetes have some retinopathy. Additional risk factors include hypertension, nephropathy, dyslipidemia, pregnancy, puberty, and smoking. Tight glycemic and blood pressure control reduce onset and progression, but rapid improvement in very poor glycemic control can transiently worsen retinopathy.
Clinical Features
Symptoms
Often asymptomatic until macular edema, vitreous hemorrhage, or retinal detachment develops
Blurred or fluctuating vision from hyperglycemia-related lens swelling or macular edema
Floaters or cobwebs from vitreous hemorrhage
Painless central vision loss from diabetic macular edema
Curtain-like field loss if tractional or combined retinal detachment occurs
Signs
Microaneurysms — earliest visible finding
Dot-blot hemorrhages, hard exudates, cotton-wool spots
Venous beading and intraretinal microvascular abnormalities (IRMA) suggest severe NPDR
Neovascularization of disc or elsewhere = proliferative diabetic retinopathy
Vitreous/preretinal hemorrhage or traction retinal detachment in advanced PDR
Macular thickening or exudates near the fovea suggest diabetic macular edema
Investigations
First-line
Dilated fundus examinationGold standard screening and staging; assess NPDR severity, PDR, and macular edema
Fundus photographyValidated retinal imaging may be used for screening and documentation, but abnormal results require eye-care follow-up
Visual acuityAssesses functional impact; vision may remain normal even with severe peripheral retinopathy
Second-line
Optical coherence tomography (OCT)Best test for diabetic macular edema; shows retinal thickening, intraretinal cysts, and subretinal fluid
Fluorescein angiographyIdentifies macular ischemia, leakage, capillary nonperfusion, and neovascularization when planning laser or evaluating unexplained vision loss
B-scan ultrasoundUseful when vitreous hemorrhage obscures fundus view and retinal detachment must be assessed
Specialist
Systemic risk assessmentHbA1c, blood pressure, lipid profile, renal function, and pregnancy status guide risk modification
Retina specialist evaluationNeeded for DME, PDR, vitreous hemorrhage, or traction retinal detachment
1
Screening
- Type 1 diabetes: first dilated eye examination 5 years after diagnosis, then at least annually depending on findings
- Type 2 diabetes: dilated eye examination at diagnosis, then at least annually depending on findings
- Pregnancy with pre-existing diabetes: eye examination before conception or in first trimester, then follow based on severity
- Gestational diabetes alone does not require the same retinopathy screening pathway unless diabetes persists
2
Systemic disease control
- Optimize glycemic control; individualized HbA1c target often around <7% when safely achievable
- Control blood pressure and lipids; treat nephropathy and smoking
- Avoid abrupt glycemic overcorrection in advanced retinopathy without close ophthalmic monitoring
3
Ocular treatment
- Center-involved diabetic macular edema with vision loss: intravitreal anti-VEGF therapy first-line
- Focal/grid laser may be used for selected non-center-involved DME or persistent focal leakage
- Proliferative diabetic retinopathy: anti-VEGF and/or panretinal photocoagulation depending on adherence, severity, and access
- High-risk PDR: prompt treatment to reduce severe vision loss risk
4
Advanced complications
- Vitreous hemorrhage: retina referral; anti-VEGF, observation, laser when view clears, or vitrectomy depending on severity/persistence
- Traction retinal detachment involving or threatening the macula: pars plana vitrectomy
- Neovascular glaucoma: urgent ophthalmology with IOP control, anti-VEGF, and PRP
Complications
- Diabetic macular edema: Leading cause of visual impairment in diabetic retinopathy
- Vitreous hemorrhage: Sudden floaters or painless vision loss from fragile neovascular vessels
- Traction retinal detachment: Fibrovascular proliferation pulls retina from RPE
- Neovascular glaucoma: Iris/angle neovascularization obstructs aqueous outflow
- Macular ischemia: Poor visual prognosis even if edema improves
USMLE Step 2 CK Exam Tips
- 1Earliest visible diabetic retinopathy finding = microaneurysms
- 2Neovascularization = proliferative diabetic retinopathy; cotton-wool spots alone do not mean proliferative disease
- 3Painless floaters in long-standing diabetes = vitreous hemorrhage from PDR
- 4Center-involved diabetic macular edema with vision loss = anti-VEGF first-line
- 5High-risk PDR can be treated with panretinal photocoagulation — it reduces severe vision loss but can reduce peripheral/night vision
- 6Type 2 diabetes: eye exam at diagnosis. Type 1 diabetes: first exam 5 years after diagnosis
- 7Pregnancy can worsen pre-existing diabetic retinopathy — examine early and monitor
- 8Macular edema can occur at any stage, including NPDR
practicetest your knowledge on diabetic retinopathyApply what you've learnt with USMLE Step 2 CK-style questions from the iatroX Q-Bank — ophthalmology and beyond.
open q-bank